Christopher B Granger Selected Research

Coronary Artery Bypass (Coronary Artery Bypass Surgery)

9/2016	2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
8/2014	In-hospital switching between clopidogrel and prasugrel among patients with acute myocardial infarction treated with percutaneous coronary intervention: insights into contemporary practice from the national cardiovascular data registry.
4/2012	Metabolic profiles predict adverse events after coronary artery bypass grafting.
3/2010	Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
11/2008	Clopidogrel use and bleeding after coronary artery bypass graft surgery.
3/2008	Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go.
8/2006	Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview.
7/2006	Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft.
11/2005	Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.
10/2005	Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher B Granger Research Topics

Disease

152	Stroke (Strokes) 01/2022 - 09/2003
150	Atrial Fibrillation 01/2022 - 05/2006
146	Myocardial Infarction 05/2022 - 07/2001
134	ST Elevation Myocardial Infarction 05/2022 - 08/2002
130	Hemorrhage 01/2022 - 10/2002
116	Heart Failure 05/2022 - 01/2002
81	Acute Coronary Syndrome 01/2022 - 07/2001
44	Embolism (Embolus) 01/2022 - 03/2010
35	Infarction (Infarctions) 01/2021 - 07/2002
31	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 06/2002
27	Thrombosis (Thrombus) 05/2022 - 05/2003
20	Hypertension (High Blood Pressure) 01/2022 - 01/2002
19	Shock 05/2022 - 09/2003
18	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2002
17	Inflammation (Inflammations) 05/2022 - 10/2005
13	Heart Arrest (Cardiac Arrest) 06/2022 - 10/2003
13	Unstable Angina 01/2019 - 07/2001
12	Transient Ischemic Attack 01/2022 - 02/2010
11	Out-of-Hospital Cardiac Arrest 06/2022 - 09/2014
10	Ischemia 12/2020 - 03/2005
9	Cardiogenic Shock 03/2020 - 10/2005
9	Body Weight (Weight, Body) 03/2020 - 10/2002
9	Coronary Disease (Coronary Heart Disease) 01/2020 - 09/2006
8	Embolic Stroke 01/2022 - 04/2014
8	Diabetes Mellitus 01/2018 - 02/2004
8	Thrombocytopenia (Thrombopenia) 12/2012 - 02/2005
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 02/2004
7	Myocardial Ischemia (Ischemic Heart Diseases) 09/2016 - 01/2002
7	Hypotension (Low Blood Pressure) 11/2010 - 09/2003
6	Peripheral Arterial Disease 10/2022 - 01/2017
6	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2014
6	Ischemic Stroke 01/2021 - 03/2010
6	Sudden Death 01/2019 - 10/2004
5	Necrosis 01/2022 - 07/2004
5	Thromboembolism 01/2022 - 01/2012
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2010

Drug/Important Bio-Agent (IBA)

90	apixabanIBA 01/2022 - 03/2010
81	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 05/2008
55	AnticoagulantsIBA 01/2022 - 11/2005
52	candesartanIBA 08/2021 - 09/2003
49	Biomarkers (Surrogate Marker)IBA 05/2022 - 08/2002
47	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 02/2002
42	pexelizumabIBA 11/2020 - 09/2003
31	Vitamin K FDA Link 01/2022 - 03/2010
27	Heparin (Liquaemin)FDA LinkGeneric 12/2012 - 02/2002
25	CreatinineIBA 01/2022 - 10/2003
18	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 04/2006
17	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 04/2006
16	Clopidogrel (Plavix)FDA Link 01/2022 - 11/2008
15	Pharmaceutical PreparationsIBA 01/2021 - 09/2003
15	Complement System Proteins (Complement)IBA 09/2013 - 09/2003
14	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 09/2003
14	TroponinIBA 01/2020 - 08/2002
12	Dabigatran FDA Link 01/2022 - 11/2011
12	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 01/2002
12	Fondaparinux (Arixtra)FDA Link 12/2010 - 03/2005
12	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010 - 10/2003
11	Glycoproteins (Glycoprotein)IBA 08/2021 - 06/2002
10	Angiotensin Receptor AntagonistsIBA 01/2022 - 10/2004
9	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 12/2003
9	MB Form Creatine KinaseIBA 10/2014 - 04/2003
9	Factor Xa InhibitorsIBA 04/2014 - 03/2005
9	Tenecteplase FDA Link 01/2010 - 04/2003
8	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2005
8	Thrombin FDA Link 01/2022 - 03/2005
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 06/2004
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 04/2004
7	darapladibIBA 01/2021 - 05/2014
7	omega-Chloroacetophenone (Mace)IBA 01/2020 - 12/2017
7	AntithrombinsIBA 01/2014 - 12/2003
6	Growth Differentiation Factor 15IBA 05/2022 - 11/2014
6	Troponin T (Troponin T1)IBA 01/2022 - 01/2014
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2019
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2005
6	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 03/2005
6	Mineralocorticoid Receptor AntagonistsIBA 08/2021 - 10/2004
6	N(4)-oleylcytosine arabinosideIBA 01/2021 - 09/2014
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 05/2003
6	Eptifibatide (Integrilin)FDA Link 02/2010 - 07/2001
6	paragonIBA 10/2007 - 07/2002
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2006 - 09/2003
5	Cystatin CIBA 01/2022 - 11/2012
5	TicagrelorIBA 01/2022 - 01/2018
5	Irbesartan FDA LinkGeneric 08/2021 - 05/2010
5	Hemoglobins (Hemoglobin)IBA 01/2020 - 02/2006
5	Troponin IIBA 02/2015 - 04/2003
5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2011 - 04/2003
5	Streptokinase FDA Link 01/2011 - 07/2002

Therapy/Procedure

153	Therapeutics 10/2022 - 07/2001
127	Percutaneous Coronary Intervention 05/2022 - 08/2003
21	Thrombolytic Therapy 01/2022 - 09/2002
16	Stents 01/2021 - 12/2003
11	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2016 - 03/2005
8	Cardiopulmonary Resuscitation (CPR) 02/2019 - 09/2014
7	Resuscitation 03/2020 - 11/2014
6	Patient Readmission 01/2021 - 11/2009
6	Critical Care (Surgical Intensive Care) 11/2019 - 10/2009
6	Length of Stay 01/2018 - 02/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
5	Blood Transfusion (Blood Transfusions) 05/2015 - 10/2004